Treatment with cyclophosphamide in elderly-onset nephrotic syndrome

Nephron - Clinical Practice

Volumn 101, Issue 1, 2005, Pages

  Mak, Siu Ka ^a   Lo, Kin Yee ^a   Wong, Calvin Y ^a   Tong, Gensy M W ^a   Wong, Ping Nam ^a   Wong, Andrew K M ^a  

^a KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

Cyclophosphamide; Nephrotic syndrome

Indexed keywords

ALBUMIN; COMPLEMENT COMPONENT C1Q; CREATININE; CYCLOPHOSPHAMIDE;

ALBUMIN BLOOD LEVEL; COMORBIDITY; CREATININE BLOOD LEVEL; DRUG TOLERABILITY; FOCAL GLOMERULONEPHRITIS; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INFORMATION RETRIEVAL; KIDNEY BIOPSY; KIDNEY FUNCTION; MEDICAL RECORD; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; REMISSION; REVIEW; SEX RATIO; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; MALE; NEPHROTIC SYNDROME; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 23844441824     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085708     Document Type: Review

References (35)

1. Davidson AM, Johnston PA: Glomerulonephritis in the elderly. Nephrol Dial Transplant 1996;11(suppl 9):34-37.
2. Donadio JV Jr: Treatment of glomerulonephritis in the elderly. Am J Kidney Dis 1990;16:307-311.
3. Kunis CL, Teng SN: Treatment of glomerulonephritis in the elderly. Sem Nephrol 2000;20:256-264.
4. O'Callaghan CA, Hicks J, Doll H, Sacks SH, Cameron JS: Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol 2002;33:157-165.
5. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG: Adult-onset minimal change nephrotic syndrome: A long-term follow-up. Kidney Int 1986;29:1215-1223.
6. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, Parson W, Bock G, Schonitzer D, Trannoy E, Grubeck-Loebenstein B: Lack of antibody production following immunization in old age: Association with CD8(+) CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002;168:5893-5899.
7. Stacy S, Krolick KA, Infante AJ, Kraig E: Immunological memory and late onset autoimmunity. Mech Age Dev 2002;123:975-985.
8. Abrass CK: Treatment of membranous nephropathy in the elderly. Semin Nephrol 2003;23:373-378.
9. Cameron JS: The nephrotic syndrome; in Davison AM, Cameron JS, Grunfeld J-P, Kerr DNS, Ritz E, Winearls CG (eds): Oxford Textbook of Clinical Nephrology, ed 2. London, Oxford University, 1998, chap 3.5.
10. Schena FP, Cameron JS: Treatment of protein-uric idiopathic glomerulonephritis in adults: A retrospective survey. Am J Med 1998;85:315-326.
11. Cameron JS: Nephrotic syndrome in the elderly. Semin Nephrol 1996;16:319-329.
12. Ponticelli C, Passerini P, Como G, Melis P, Vigano E, Pozzi C, Altieri P: Primary nephrotic syndrome in the elderly. Contrib Nephrol. Basel, Karger, 1993, vol 105, pp 33-37.
13. Zent R, Nagai R, Cattran DC: Idiopathic membranous nephropathy in the elderly: A comparative study. Am J Kidney Dis 1997;29:200-206.
14. Glassock RJ: Glomerular disease in the elderly population. Geriatr Nephrol Urol 1998;8:149-154.
15. Levison SP: Renal disease in the elderly: The role of the renal biopsy. Am J Kidney Dis 1990;16:300-306.
16. Warwick GL, Geddes CG, Boulton-Jones JM: Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure. Q J Med 1994;87:223-229.
17. Al-Khader AA, Lien JWK, Aber GM: Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis. Clin Nephrol 1979;11:26-30.
18. Meyrier A: Use of cyclosporine in the treatment of idiopathic nephrotic syndrome in adults. Contrib Nephrol. Basel, Karger, 1995, vol 114, pp 28-48.
19. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, et al: Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 1993;8:1326-1332.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
21. Churg J, Bernstein J, Glassock RJ: Renal Disease: Classification and Atlas of Glomerular Diseases. New York, Igaku-Shoin, 1995.
22. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993;329:85-89.
23. Lai FM, Lai KN, Chan KW, Au TC, Tong KL, Vallance-Owen J: Pattern of glomerulonephritis in Hong Kong. Pathology 1987;19:247-252.
24. Jennette JC, Falk RJ: Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis 1990;16:432-437.
25. Mak SK, Short CD, Mallick NP: Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant 1996;11:2192-2201.
26. Passerini P, Como G, Viganò E, Melis P, Pozzi C, Altieri P, Ponticelli C: Idiopathic membranous nephropathy in the elderly. Nephrol Dial Transplant 1993;8:1321-1325.
27. Bizzarri D, Imperiali P, Duranti E, Sasdelli M: Idiopathic membranous glomerulonephritis in the elderly. Contrib Nephrol. Basel, Karger, 1993, vol 105:65-70.
28. Rollino C, Basolo B, Roccatello D, Vallero A, Funaro L, Piccoli G: Outcome of membranous glomerulonephritis in the elderly. Contrib Nephrol. Basel, Karger, 1993, vol 105, pp 71-74.
29. Uldall PR, Feest TG, Morley AR, Tomlinson BE, Kerr DNS: Cyclopkosphamide therapy in adults with minimal-change nephrotic syndrome. Lancet 1972;i:1250-1253.
30. Ali H: Renal disease in the elderly. Postgrad Med 1996;100:44-57.
31. Ponticelli C; Villa M: Does cyclosporin have a role in the treatment of membranous nephropathy? Nephrol Dial Transplant 1999;14:23-25.
32. Branten AJW, Wetzels JFM for the Study Group: Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Clin Nephrol 2001;56:1-9.
33. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-498.
34. Seyffart G: Drug Dosage in Renal Insufficiency. Dordrecht, Kluwer Academic Publishers, 1991, pp 167-168.
35. Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D: Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency. Kidney Int 2002;61:1495-1501.